EVENTS

Join speakers:
M. Peter Marinkovich M.D. (USA): Associate Professor of Dermatology at Stanford University School of Medicine, Director of the Blistering Disease Clinic at Stanford Health Care and the VA Palo Alto Dermatology service. His research focuses on the pathogenesis and therapy of Epidermolysis Bullosa (EB) including gene-therapy approaches (for example he was involved in the first ex vivo gene therapy trial for dystrophic EB).
Natividad Romero Haro (Spain): Nurse and Coordinator of care and training activities at DEBRA Piel de Mariposa (Spain). For over 17 years she has worked closely with families affected by EB, coordinating a multidisciplinary team (nurses, psychologists, social workers) and focusing on holistic care and training of professionals.

This exclusive session will provide a comprehensive overview of the latest approved and emerging treatments for EB, along with the newest wound-care medical devices now entering the market. Our speakers will share expert insights, clinical perspectives, and practical guidance to support both patients and healthcare professionals.

This webinar is a unique opportunity to stay informed about the evolving therapeutic landscape for EB—knowledge that can directly support better care, better decisions, and better quality of life.